Tredje AP-fonden’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.8M | Buy |
97,645
+31,271
| +47% | +$11.6M | 0.17% | 113 |
|
|
2026
Q1 | $19.4M | Buy |
+66,374
| New | +$21.8M | 0.11% | 185 |
|
|
2025
Q2 | – | Sell |
-32,904
| Closed | -$14.3M | – | 393 |
|
|
2025
Q1 | $14.3M | Hold |
32,904
| – | – | 0.13% | 118 |
|
|
2024
Q4 | $12.1M | Sell |
32,904
-22,012
| -40% | -$9.21M | 0.11% | 151 |
|
|
2024
Q3 | $28.6M | Sell |
54,916
-24,392
| -31% | -$13M | 0.26% | 77 |
|
|
2024
Q2 | $43M | Sell |
79,308
-13,406
| -14% | -$7.09M | 0.41% | 54 |
|
|
2024
Q1 | $48.1M | Buy |
92,714
+482
| +0.5% | +$240K | 0.5% | 50 |
|
|
2023
Q4 | $43.5M | Sell |
92,232
-41,060
| -31% | -$19M | 0.54% | 46 |
|
|
2023
Q3 | $58M | Buy |
133,292
+3,546
| +3% | +$1.61M | 0.86% | 25 |
|
|
2023
Q2 | $57.6M | Buy |
129,746
+25
| +0% | +$11.5K | 0.82% | 26 |
|
|
2023
Q1 | $59.6M | Buy |
129,721
+10,923
| +9% | +$5.2M | 0.93% | 20 |
|
|
2022
Q4 | $60.9M | Buy |
118,798
+77,403
| +187% | +$39.3M | 1.04% | 17 |
|
|
2022
Q3 | $18.8M | Buy |
41,395
+12,484
| +43% | +$5.97M | 0.39% | 63 |
|
|
2022
Q2 | $14M | Buy |
28,911
+4,000
| +16% | +$1.98M | 0.35% | 61 |
|
|
2022
Q1 | $12.2M | Buy |
24,911
+5,000
| +25% | +$2.29M | 0.25% | 88 |
|
|
2021
Q4 | $9.23M | Buy |
19,911
+1,254
| +7% | +$528K | 0.18% | 113 |
|
|
2021
Q3 | $6.96M | Hold |
18,657
| – | – | 0.15% | 131 |
|
|
2021
Q2 | $7.12M | Hold |
18,657
| – | – | 0.15% | 107 |
|
|
2021
Q1 | $6.7M | Hold |
18,657
| – | – | 0.16% | 106 |
|
|
2020
Q4 | $5.99M | Hold |
18,657
| – | – | 0.15% | 111 |
|
|
2020
Q3 | $5.01M | Hold |
18,657
| – | – | 0.16% | 98 |
|
|
2020
Q2 | $4.91M | Hold |
18,657
| – | – | 0.2% | 89 |
|
|
2020
Q1 | $4.24M | Buy |
18,657
+3,073
| +20% | +$837K | 0.22% | 94 |
|
|
2019
Q4 | $4.71M | Sell |
15,584
-6,537
| -30% | -$1.8M | 0.24% | 106 |
|
|
2019
Q3 | $5.31M | Buy |
22,121
+3,060
| +16% | +$838K | 0.25% | 97 |
|
|
2019
Q2 | $5.38M | Sell |
19,061
-9
| -0% | -$2.46K | 0.26% | 90 |
|
|
2019
Q1 | $5.47M | Sell |
19,070
-1,420
| -7% | -$411K | 0.28% | 85 |
|
|
2018
Q4 | $5.38M | Buy |
20,490
+801
| +4% | +$220K | 0.33% | 76 |
|
|
2018
Q3 | $5.4M | Sell |
19,689
-14,608
| -43% | -$3.79M | 0.26% | 91 |
|
|
2018
Q2 | $8.16M | Sell |
34,297
-9,050
| -21% | -$2.1M | 0.28% | 106 |
|
|
2018
Q1 | $9.52M | Sell |
43,347
-180
| -0.4% | -$42.3K | 0.34% | 73 |
|
|
2017
Q4 | $9.79M | Buy |
43,527
+6,070
| +16% | +$1.29M | 0.33% | 68 |
|
|
2017
Q3 | $7.11M | Sell |
37,457
-361
| -1% | -$68.7K | 0.25% | 99 |
|
|
2017
Q2 | $7.12M | Sell |
37,818
-6,173
| -14% | -$1.11M | 0.27% | 98 |
|
|
2017
Q1 | $7.28M | Buy |
43,991
+13,413
| +44% | +$2.13M | 0.29% | 86 |
|
|
2016
Q4 | $4.4M | Sell |
30,578
-733
| -2% | -$98.1K | 0.19% | 147 |
|
|
2016
Q3 | $3.92M | Sell |
31,311
-5,676
| -15% | -$733K | 0.18% | 148 |
|
|
2016
Q2 | $4.86M | Buy |
36,987
+5,884
| +19% | +$805K | 0.22% | 100 |
|
|
2016
Q1 | $4.34M | Buy |
31,103
+13,698
| +79% | +$1.83M | 0.2% | 105 |
|
|
2015
Q4 | $2.43M | Buy |
17,405
+164
| +1% | +$22.6K | 0.16% | 132 |
|
|
2015
Q3 | $2.41M | Sell |
17,241
-1,868
| -10% | -$281K | 0.24% | 111 |
|
|
2015
Q2 | $3.14M | Buy |
+19,109
| New | +$3.05M | 0.25% | 104 |
|
Other funds holding ELV
Tredje AP-fonden's ELV Position: Q2 2026 in Review
Tredje AP-fonden increased its Elevance Health (ELV) stake by 47% in Q2 2026, buying an estimated $11.6M and bringing the position to 97,645 shares worth $37.8M. The position accounts for 0.17% of the portfolio, ranked #113.
Tredje AP-fonden first reported a position in ELV in Q2 2015 and has held it in 42 quarters since. The position peaked at $60.9M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Tredje AP-fonden held 97,645 shares of Elevance Health worth $37.8M as of Q2 2026.
- Tredje AP-fonden bought 31,271 Elevance Health shares in Q2 2026, an estimated $11.6M.
- Elevance Health made up 0.17% of Tredje AP-fonden's portfolio in Q2 2026, its #113 holding.
- Tredje AP-fonden first reported a position in Elevance Health in Q2 2015 and has held it in 42 quarters since.
- Tredje AP-fonden's Elevance Health position peaked at $60.9M in Q4 2022.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.